| |

Dr.
Spitler and her team have been working together for many years to provide
information to patients and the medical community regarding therapeutic
options for patients with melanoma. The team consists of physicians representing
all of the specialties concerned with melanoma:
- Lynn E. Spitler, M.D., Director, Immunology
- Robert Weber, M.D., Associate Director, Oncology
- Ruth Marlin, M.D., Associate Director, Integrative Oncology
- Robert Allen, M.D., Surgical Oncology
- Cecily FitzGerald, M.D., Melanoma Fellow
- John Meyer, M.D., Radiation Oncology
- Robert Murray, M.D., Surgery
- Alice Do, M.D., Dermatology
| |
 |
More than 5,000 patients have come to the Melanoma Center for consultation regarding melanoma. At the time of the first consultation, the patientís records are reviewed in detail and he/she undergoes a history and physical examination. There is a review of operative, pathology and laboratory test reports, radiological procedures and all past therapies. If appropriate, the patientís slides, X-rays, and scans are also reviewed. In selected cases, the patientís care is discussed by the Consulting Panel.
The patient, family members, and/or friends meet with Dr. Spitler, and the recommendations for any diagnostic tests needed and therapeutic options are discussed. The goal is to provide patients and their loved ones with information to allow them to make informed decisions regarding therapeutic options.
After the initial consultation, patients with melanoma are encouraged
to have regular follow-up with us and/or with their regular oncologist.
Should a problem arise, the patient’s case will be discussed again
by the Consulting Panel.
The Northern California Melanoma Center is currently engaged in a major
research effort aimed at developing more effective therapies for malignant
melanoma. Many of these studies include using investigational immunotherapy.
|
|
|